Alert: Renacet 475 mg and 950mg film-coated tablets

RenaCare NephroMed GmbH has informed the MHRA of the presence of an undeclared excipient in the coating of Renacet 475 mg and 950mg film-coated tablets, affecting 21 batches.

This excipient is Macrogol 6000, which has always been included in Renacet Tablets but has been omitted from the list of excipients in error.

Prescribers are advised they can continue to provide these tablets to patients and patients should continue to take tablets from these batches as prescribed by your healthcare professional.

MHRA alert

Latest news

England & Wales: initial August concession price update

The Department of Health and Social Care has published an initial update to the initial list of August concessions. In this update, there are 48 new prices DDA members can download a fully updated spreadsheet of the Aug

New CD guidance for limited companies

The DDA and the Healthcare Distribution Association (HDA) has published joint guidance on the supply of Controlled Drugs to GP practices constituted as a limited company. In summary, two core regulatory requirements apply: Care regulator registra

Dispensing cross subsidy highlighted in rural GP funding critique

The role of dispensing income as a cross subsidy for rural NHS GP funding has been highlighted in a new paper by a think-tank. Noting the funding challenges of delivering NHS GP services in rural areas, General practice funding in England publ

Alert: Renacet 475 mg and 950mg film-coated tablets

Latest news

England & Wales: initial August concession price update

New CD guidance for limited companies

Dispensing cross subsidy highlighted in rural GP funding critique

View all news

Gold Supporters

Follow us

Dispensing Doctors' Association

DDA Best Practice Group

Dispensing Doctors' Association